Vol. 19 No. 3 (2015)
CORONARY ARTERY DISEASES

Risks of complications in coronary artery bypass grafting when using effective pulmonary ventilation

PDF (Русский)
  • O. Kamenskaya,
  • A. Klinkova,
  • V. Lomivorotov,
  • D. Ponomarev,
  • A. Cherniavsky,
  • A. Karaskov
O. Kamenskaya
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
Bio
A. Klinkova
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
Bio
V. Lomivorotov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
Bio
D. Ponomarev
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
Bio
A. Cherniavsky
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
Bio
A. Karaskov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
Bio
DOI: https://doi.org/10.21688/1681-3472-2015-3-68-73

Published 2015-10-27

Keywords

  • coronary artery disease,
  • efficiency of pulmonary ventilation

How to Cite

Kamenskaya, O., Klinkova, A., Lomivorotov, V., Ponomarev, D., Cherniavsky, A., & Karaskov, A. (2015). Risks of complications in coronary artery bypass grafting when using effective pulmonary ventilation. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 19(3), 68–73. https://doi.org/10.21688/1681-3472-2015-3-68-73

Copyright (c) 2015 Kamenskaya O.V., Klinkova A.S., Lomivorotov V.V., Ponomarev D.N., Cherniavsky A.M., Karaskov A.M.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Objective. The study was to evaluate the risk of cardio-respiratory complications in patients with coronary heart disease (CHD) who received coronary artery bypass grafting (CABG) with regard to the efficiency of pulmonary ventilation.
Methods. Our study included 144 CHD patients. Body plethysmography and spiroergometry at rest were used to study the respiratory function and consumption of O2. To evaluate the effectiveness of pulmonary ventilation, the coefficient of oxygen utilization (O2CU) was then calculated. The first group consisted of 93 patients with O2CU more than 25 ml /L, the second group included 51 patients with O2CU less than 25 ml / L.
Results. In the second group we registered more pronounced impairment of respiratory biomechanics toward the obstructive component, as compared to the first group. Also, in the second group there was a higher percentage of patients with concomitant chronic obstructive pulmonary disease (COPD), type 2 diabetes mellitus (DM) and multifocal atherosclerosis in comparison with the first group (p<0.05). After CABG, in the second group, as compared to the first one, we observed more patients with respiratory failure (RF), atrial fibrillation (AF), cognitive disorders and prolonged mechanical ventilation (MV) (p<0.05).
Conclusion. Concurrent COPD in patients with CHD triples the chances of developing RF after CABG. A significant reduction in the efficiency of pulmonary gas exchange (O2CU less than 20 ml/l) increases the risks of developing RF and prolonged MV after CABG by 2.9 and 2.2 times respectively. Prolonged MV after CABG leads to a 1.9-fold increase in AF development.

PDF (Русский)

References

  1. Бойцов С.А., Никулина Н.Н., Якушин С. С. и др. Внезапная сердечная смерть у больных ишемической болезнью сердца: по результатам Российского многоцентрового эпидемиологического исследования заболеваемости, смертности, качества диагностики и лечения острых форм ИБС // Российский кардиологический журнал. 2011. № 2. С. 59–64.
  2. Weisel R.D., Nussmeier N., Newman M.F. et al. RED-CABG Executive and Steering Committees. Predictors of contemporary coronary artery bypass grafting outcomes // J Thorac Cardiovasc Surg. 2014. Vol. 148. № 6. P. 2720–2726.
  3. Баутин А.Е., Хубулава Г.Г., Наумов А.Б. и др. Неинвазивная вентиляция легких при ОРДС у кардиохирургических больных // Общая реаниматология. 2007. Т. 3. № 3. С. 65–70.
  4. Бокерия Л.А., Голухова Е.З., Алекян Б.Г. и др. Непосредственные результаты хирургического и эндоваскулярного лечения больных ишемической болезнью сердца: периоперационные осложнения, факторы риска, прогноз // Креативная кардиология. 2011. № 1. С. 41–60.
  5. Бокерия Л.А., Голухова Е.З., Мерзляков В.Ю. и др. Факторы риска и система прогнозирования развития послеоперационных легочных осложнений у кардиохирургических пациентов // Креативная кардиология. 2011. № 2. С. 24–36.
  6. Лутра А. ЭхоКГ понятным языком. М.: Практическая медицина. 2011. 258 c.
  7. Бокерия Л.А, Шаталов К.В., Колоскова Н.Н. Определение функции внешнего дыхания у пациентов с хронической сердечной недостаточностью // Клиническая физиология кровообращения. 2012. № 4. С. 5–8.
  8. Караськов А.М., Каменская О.В., Клинкова А.С. и др. Хроническая сердечная недостаточность и состояние функции внешнего дыхания у пациентов с ишемической болезнью сердца // Сердечная недостаточность. 2014. Т. 15. № 2. С. 90–94.
  9. Клинкова А.С., Каменская О.В., Караськов А.М. Функция внешнего дыхания у больных ишемической болезнью сердца в сочетании с хронической обструктивной болезнью легких // Патология кровообращения и кардиохирургия. 2014. № 2. С. 27–31.
  10. Kido T., Tamagawa E., Bai N. et al. Particulate matter induces translocation of IL-6 from the lung to the systemic circulation // Am J Respir Cell Mol Biol. 2011. Vol. 44. № 2. P. 197–204.
  11. Van Eeden S., Leipsic J., Paul Man S.F. et al. The relationship between lung inflammation and cardiovascular disease // Am J Respir Crit Care Med. 2012. Vol. 186. № 1. P. 11–16.
  12. Hogg J.C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease // Lancet. 2004. Vol. 364. P. 709–721.
  13. Панина М.И. Патофизиологические аспекты гипервентиляции и гипервентиляционного синдрома // Казанский медицинский журнал. 2003. № 4. С. 288–293.